TXG Insider Trading Activity and SEC Form 4 Filings
TXG insider trading summary
Over the past 12 months, insiders at 10x Genomics, Inc. (TXG) reported 49 sales worth $16.7M by 6 insiders and no open-market purchases on SEC Form 4. Net insider selling was $16.7M.
Latest TXG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Shehnaaz Suliman | Insider | Sell | $107K (1,325 @ $80.82) |
| Sep 22, 2026 | Shehnaaz Suliman | Insider | Sell | $185K (2,270 @ $81.67) |
| Sep 22, 2026 | Serge Saxonov | Chief Executive Officer | Sell | $231K (2,800 @ $82.36) |
| Sep 22, 2026 | Shehnaaz Suliman | Insider | Sell | $49K (614 @ $79.51) |
| Sep 22, 2026 | Serge Saxonov | Chief Executive Officer | Sell | $752K (9,300 @ $80.90) |
| Sep 22, 2026 | Shehnaaz Suliman | Insider | Sell | $23K (292 @ $78.20) |
| Sep 22, 2026 | Serge Saxonov | Chief Executive Officer | Sell | $78K (1,000 @ $78.23) |
| Sep 22, 2026 | Serge Saxonov | Chief Executive Officer | Sell | $159K (2,000 @ $79.62) |
| Sep 22, 2026 | Serge Saxonov | Chief Executive Officer | Sell | $810K (9,900 @ $81.83) |
| Sep 22, 2026 | Shehnaaz Suliman | Insider | Sell | $101K (1,222 @ $82.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.